Guangdong Hengrui Pharmaceutical Co., Ltd

This study tests a new medicine called SHR-1139 for people with pyoderma gangrenosum, a rare skin condition that causes painful ulcers. The goal is to see if the drug can fully close the ulcers and keep them closed. About 20 adults will take part in this early-stage trial.

This early-stage study tests a new inhaled medicine called HRS-9821 for COPD. It will first check safety in 48 healthy volunteers and then in people with COPD. The goal is to see if the drug is safe and how it moves through the body.

This study is testing whether an investigational injection called SHR-2173 can help control IgA nephropathy, a kidney disease where protein leaks into the urine. About 84 adult patients will receive either the real injection or a placebo (dummy shot) for 48 weeks to see if it saf…